PCM
DVAX

Penserra Capital Management’s Dynavax Technologies DVAX Stock Holding History

Penserra Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-544,158
Closed -$10.5M – 1417
2021
Q3 		$10.5M Buy
+544,158
New +$7.23M 0.22% 133

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Penserra Capital Management's DVAX Position: Q4 2021 in Review

Penserra Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 544,158 shares — an estimated $10.5M sold.

Penserra Capital Management first reported a position in DVAX in Q3 2021 and held it in 1 quarter. The position peaked at $10.5M in Q3 2021. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

  • Penserra Capital Management reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 544,158 Dynavax Technologies shares in Q4 2021, an estimated $10.5M.
  • Penserra Capital Management first reported a position in Dynavax Technologies in Q3 2021 and held it in 1 quarter.
  • Penserra Capital Management's Dynavax Technologies position peaked at $10.5M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.